Lentiviruses are the backbone of many engineered cell therapies, but remain expensive to make and difficult to scale. Our LV Edge system can help. Part I of II.
Excellent article! I wonder what your team thinks about non-viral engineering strategies for cell therapies? They could overcome some of the cost and complexities associated with lentiviral vectors, but would perhaps be more limited by GMP plasmid production. Curious on your take there.
excellent ...article
Excellent article! I wonder what your team thinks about non-viral engineering strategies for cell therapies? They could overcome some of the cost and complexities associated with lentiviral vectors, but would perhaps be more limited by GMP plasmid production. Curious on your take there.